Preclinical HbA1c level studies of Brihat Khadir Batika and Chandraprabha Batika after chronic administration to male Sprague-Dawley rats

Abstract

Background: Brihat Khadir Batika (BKD) and Chandraprabha Batika (CPB) are Ayurvedic preparations used as traditional medicines for different clinical indications in the rural population. BKD is used in diseases of throat and CPB is used in glandular enlargement. In this study we evaluate the influence of these preparations on HbA1c (%) level.Methods: To find out the average plasma glucose concentration over prolonged period of time, Ayurvedic medicinal preparations BKD and CPB were administered chronically to the male Sprague-Dawley rats at a dose of 400 mg/kg. After 28 days of chronic administration of BKD and CPB the following changes were noted. In this experiment Glycated Hemoglobin A1C level was determined.Results: The results of the study of in vitro quantitative determination of rat Glycated hemoglobin A1c concentrations in serum studies are thus: BKD caused a statistically insignificant (p=0.066) increase in the HbA1c level of the male rat (16.87% increase). CPB demonstrated a statistically insignificant (p=0.079) (17.47%) increase in the HbA1C level of the blood of the male rat.Conclusions: Both preparation BKD and CPB found in increasing HbA1c level of the blood of the male rat.

Steroidal and gonadotropin hormone profile studies of a classical ayurvedic preparation of “Saraguna Balijarita Makardhwaja” after chronic administration to male Sprague-Dawley rats

“…10 From several chronic investigations in rats it has been reported that only plant-based ayurvedic remedies have long-term deleterious effects on organs such as the liver, kidney, and spleen, as well as the glycemic index. [11][12][13][14] More importantly, there are extremely limited toxicity investigations on Ayurvedic drugs. Thus, it is necessary to determine a safety profile assessment of Ayurvedic drugs.…”